Royce & Associates’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,811
Closed -$37K 975
2022
Q1
$37K Buy
+11,811
New +$37K ﹤0.01% 957